MatchaDB

2025Tesis o disertaciónLectura gratuita

Comparative bioactivity analysis of green and dark teas via metabolomics and in-silico modelling

Autores no indicados

UpSpace Institutional Repository (University of Pretoria)

Texto completo gratuito→

Resumen

Green and dark teas are rich in bioactive compounds with potential therapeutic effects in the management of type 2 diabetes mellitus (T2DM). This study aimed to comprehensively evaluate the antidiabetic potential of green and dark teas through an integrated experimental and computational workflow, incorporating metabolomics, enzyme inhibition assays, antioxidant assays, liver cell-based assays, and molecular modelling. A total of 24 commercially available tea samples, green, dark, black, matcha, and rooibos were sourced, and these teas were subjected to untargeted liquid chromatography-mass spectrometry (LC/MS) based metabolomics in negative ion mode to characterise their chemical compositions. Matcha tea served as a positive control due to its well-documented bioactivity, while rooibos served as a negative control since it is derived from a botanically unrelated plant. Black tea was included to differentiate metabolites arising from microbial fermentation in dark tea versus those generated via enzyme oxidation found in black tea. Metabolomic profiling revealed that green and dark teas share a core set of polyphenolic compounds, including epigallocatechin gallate (EGCG), epicatechin gallate (ECG), and gallic acid. Each tea exhibited unique signatures linked to fermentation and processing. Dark teas also contained additional fermentation-related metabolites such as ellagic acid derivatives and esculetin. Enzyme inhibition assays showed that green tea exhibited the strongest inhibition of both α-glucosidase (IC₅₀ = 20.09 ± 3.22 µg/mL) and α-amylase (IC₅₀ = 1.59 ± 0.11 mg/mL), showing significantly greater activity than the other teas (α < 0.001). Matcha and black teas displayed moderate inhibition (α > 0.05 between them), while dark tea showed weaker activity (IC₅₀ =…

Resumen acortado. Leer el resumen completo en la fuente.

El texto del resumen procede de PubMed, OpenAlex o Europe PMC y pertenece a los autores y al editor.

Tipo de estudio

Ensayo controlado aleatorizado

Se asignó a las personas al azar a matcha o a una comparación.

Asignado automáticamente a partir del título, el resumen y los términos temáticos.

Temas

El matcha es un tema principal aquí (nombrado en las palabras clave).

Palabras clave y términos temáticos

Tu carpeta de investigación

Citar este estudio

(2025). Comparative bioactivity analysis of green and dark teas via metabolomics and in-silico modelling. UpSpace Institutional Repository (University of Pretoria).

Más sobre Metabolismo y peso

2023Artículo de revista

Monitoring chlorophyll changes during Tencha processing using portable near-infrared spectroscopy.

Liu L, Zareef M, Wang Z, et al. — Food chemistry

Monitoring chlorophyll during Tencha (the raw ingredient for matcha) processing is critical for determining the matcha's color and quality. The purpose of this study is to explore the mechanism of chlorophyll changes during Tencha…

Química / analíticaCultivo y sombreadoProcesado, molienda y calidadAutenticidad y métodos analíticosCitado 106×
2018Artículo de revistaLectura gratuita

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

In vitro / estudio celularMetabolismo y pesoAntioxidantes y polifenolesCáncerCitado 75×
2020Artículo de revista

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJ, et al. — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

Estudio en animalesMetabolismo y pesoIntestino y microbiomaMercado, cultura y sostenibilidadCitado 74×

Explorar toda la biblioteca→